MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
October 28, 2004
Brian Gorman
Cardinal's Good News: No News The drug wholesaler took a major step toward rehabilitating itself with the release of its 10-K. mark for My Articles similar articles
The Motley Fool
July 28, 2004
Brian Gorman
Cardinal Watching Cardinal Health continues to be pummeled, but wait patiently, because a buying opportunity could emerge. mark for My Articles similar articles
The Motley Fool
October 26, 2005
Stephen D. Simpson
Cardinal's Tweet More Sweet Changes at the giant manufacturer, distributor, and service provider in the health-care industry are working out well, but the stock price already reflects it. mark for My Articles similar articles
The Motley Fool
December 10, 2004
Brian Gorman
Cardinal Picks a Lilly Cardinal Health's deal with Lilly suggests the new fee-for-service model is gaining traction. mark for My Articles similar articles
The Motley Fool
June 13, 2006
Ryan Fuhrmann
Cardinal Looks to Deliver Cardinal Health has been through a tumultuous couple of years but appears to have weathered company-specific and industry storms. If the drug distributor can meet its long-term goals, then its stock should represent a long-term solid investment. mark for My Articles similar articles
The Motley Fool
January 30, 2006
Brian Gorman
Cardinal Inches Higher The distribution is looking healthier, but Cardinal Health still has work to do. Investors, take note. mark for My Articles similar articles
The Motley Fool
June 28, 2005
Brian Gorman
Cardinal Changes Course The health care company's warning is a disappointment, but the firm's new focus on returning cash to shareholders is far from bad news. mark for My Articles similar articles
The Motley Fool
November 7, 2007
Billy Fisher
Cardinal Has Its Wings Clipped Despite a healthy year-over-year pop of 15% in EPS from operations, much of the focus in the first-quarter was shifted to a weak performance by Cardinal's pharmaceutical services segment. mark for My Articles similar articles
The Motley Fool
May 6, 2005
W.D. Crotty
McKesson's New Pep Pill The drug wholesaler reports strong fourth-quarter results as it moves to a fee-for-service model. mark for My Articles similar articles
The Motley Fool
January 26, 2007
Billy Fisher
A Clean Bill of Health at Cardinal Good results and a key divestiture have this health care company rolling. Investors, take note. mark for My Articles similar articles
The Motley Fool
August 3, 2006
Ryan Fuhrmann
Cardinal Distributes the Goods The drug wholesaler and distributor has to regain investor confidence and rebuild a track record in a changed industry. So far, so good for 2006. Let's see if any further information can be found once Cardinal submits its 10-K filing to the SEC. mark for My Articles similar articles
The Motley Fool
May 2, 2005
Brian Gorman
Cardinal Health Perks Up The drug distribution company is working through its problems, which should make for a brighter fiscal 2006. Investors, take note. mark for My Articles similar articles
The Motley Fool
January 18, 2005
Brian Gorman
Cardinal Doesn't Get Ruffled The drug distributor's potential loss of Japanese pharmaceutical Eisai will hurt in the short term, but fortunately for investors Cardinal Health continues to plan wisely. mark for My Articles similar articles
The Motley Fool
September 30, 2008
Brian Orelli
Cardinal Health Clips Its Wings Does it make sense for the drug wholesaler to spin off its medical equipment business? mark for My Articles similar articles
The Motley Fool
May 20, 2004
Tom Taulli
Cardinal Rules of M&A Cardinal Health is upbeat on its latest acquisition, but needs bigger deals to push growth. mark for My Articles similar articles
The Motley Fool
January 2, 2004
Alyce Lomax
A Bitter Pill for Amerisource Veterans ditch Amerisource for rival; investors punish the entire pharmaceutical distribution industry. mark for My Articles similar articles
The Motley Fool
July 1, 2004
W.D. Crotty
Drug Wholesalers Taking a Beating A sharp drop at drug wholesaler Cardinal Health provides a unique buying opportunity. mark for My Articles similar articles
The Motley Fool
October 8, 2007
Billy Fisher
McKesson Expands Its Empire A new acquisition strengthens the company's presence in the cancer drug market. Investors, take note. mark for My Articles similar articles
The Motley Fool
January 21, 2005
Rich Duprey
Cardinal Back in the Nest Drug distributor and Japanese pharma Eisai come to agreement after all. mark for My Articles similar articles
The Motley Fool
October 18, 2005
Stephen D. Simpson
More Good News From Novartis This Swiss drug giant continues to post steady growth. Investors, take note. mark for My Articles similar articles
BusinessWeek
November 24, 2003
Roger O. Crockett
Cardinal Health, Heal Thyself CEO Walter aims to revive growth, selling high-tech gear and expanding overseas. mark for My Articles similar articles
The Motley Fool
November 8, 2011
Brandon Glenn
Cardinal Health Looks to Build China Business, but Has Long Way to Go For pharmaceuticals distributor Cardinal Health, China represents a world of opportunity. mark for My Articles similar articles
The Motley Fool
August 24, 2011
Brandon Glenn
Cardinal Health Sees Opportunity (but Faces Challenges) in Specialty Drugs Is Cardinal up for the challenge? mark for My Articles similar articles
The Motley Fool
April 26, 2004
Alyce Lomax
Amerisource Hangs On While pharmaceutical distribution is an industry with obvious opportunities for financial reward, the potential for a price war remains a risk. mark for My Articles similar articles
Financial Planning
September 1, 2007
Glenn G. Kautt
Helping the Handoff Survey results show that business owners are in need of help when it comes to transition planning. There are four phases in the transition of a business where advisors can help their clients. mark for My Articles similar articles
The Motley Fool
June 27, 2011
Brandon Glenn
Cardinal Health Products Won't Be in Cleveland Medical Mart (or Any Other) Once an early high-profile supporter of the medical mart concept, drug distributor Cardinal Health has had an apparent change of opinion. mark for My Articles similar articles
The Motley Fool
October 12, 2004
W.D. Crotty
A Bargain in Drug Distribution? D&K Healthcare Resources' stock surprises investors, but the drop brings a favorable valuation. mark for My Articles similar articles
The Motley Fool
April 19, 2006
Brian Gorman
Pfizer Inches Forward The pharma continues on cost-cutting and gives back to shareholders, but R&D productivity remains a tough challenge. mark for My Articles similar articles
The Motley Fool
April 7, 2011
Brandon Glenn
"Generic Wave" to Drive Cardinal Health's Profitability in Coming Years The generic wave could mean big money for Cardinal and top competitors. mark for My Articles similar articles
The Motley Fool
March 23, 2011
Jordan DiPietro
Should You Buy and Hold Cardinal Health? Does this company have the traits of a good retirement stock? mark for My Articles similar articles
Pharmaceutical Executive
October 1, 2011
30 Years of Pharma: Perspective in Numbers Top 10 pharmaceutical products worldwide. mark for My Articles similar articles
The Motley Fool
April 15, 2005
Selena Maranjian
You're Too Late for This Fund When one good fund closes, others are still open. mark for My Articles similar articles
The Motley Fool
July 28, 2005
Tom Taulli
Is Sun Getting Eclipsed? Maybe the best strategy for Sun is just to give money back to its shareholders. mark for My Articles similar articles
The Motley Fool
May 2, 2008
Steven Renaldi
Cardinal Health Gets Its Nest in Order Share price rises as investors hope the company is beginning to put some of its troubles behind it. mark for My Articles similar articles
Pharmaceutical Executive
November 1, 2008
Tousi & Lee
Making Sense of Sales The direct sales force is one of the largest costs for most pharma companies, but don't throw out sales force effectiveness with the sales force when cutting costs. Read on for some sure-fire strategies. mark for My Articles similar articles
Chemistry World
March 3, 2015
Phillip Broadwith
J&J to sell cardiac devices to wholesaler Cardinal Johnson & Johnson has agreed to sell its cardiovascular surgical devices subsidiary, Cordis, to wholesale supplier Cardinal Health. mark for My Articles similar articles
The Motley Fool
May 18, 2004
Selena Maranjian
A Daring but Doomed Proposal What if shareholders decided how companies spent their money? mark for My Articles similar articles
The Motley Fool
January 26, 2005
Stephen D. Simpson
Sanofi's Balancing Act A broad portfolio of drugs helps the French pharmaceutical stay ahead of its peers. It's a good option for investors who want a strong growth stock in the pharmaceutical space but don't want to take on the risks of turnarounds or litigation. mark for My Articles similar articles
The Motley Fool
August 17, 2007
Brian Lawler
The Perfect Pharma Acquisition The pharmaceutical industry has been busy consolidating in the past year. With so much buying and selling going on, here is speculation on what would constitute the perfect pharma acquisition. mark for My Articles similar articles
Pharmaceutical Executive
February 1, 2011
Frederic Brunner
Growing Stronger After the Storm To manage through a resource-constrained environment, it is essential to get the most out of procurement planning mark for My Articles similar articles
The Motley Fool
June 14, 2007
Nathan Parmelee
Target Releases Arrows Made of Money The retailer has done well by shareholders, and might do even better. mark for My Articles similar articles
Pharmaceutical Executive
October 1, 2011
30 Years of Pharma: Perspective in Numbers, Part 2 Top 10 pharmaceutical companies by market share. mark for My Articles similar articles
The Motley Fool
May 6, 2008
Steven Renaldi
McKesson Garners Generic Growth New products offer the generic-drug distributor profit potential in a competitive industry. mark for My Articles similar articles
The Motley Fool
May 6, 2008
Alyce Lomax
When Shareholders Speak ... AFLAC Listens The insurance company blazes a trail in letting shareholders have a say on management's pay. mark for My Articles similar articles
BusinessWeek
August 30, 2004
Gene G. Marcial
PSS Is Really Delivering The Goods When David Smith took the CEO job at PSS World Medical in 2000, sales stood at $160 million. They've since rocketed to $1.35 billion. No wonder industry giants are eyeballing the company: They hope Smith will sell. mark for My Articles similar articles
The Motley Fool
December 8, 2004
Alyce Lomax
Eli Lilly Bares All The pharmaceutical publishes clinical trial results online. This is a step toward generating trust -- after all, shareholders, physicians, and consumers alike are likely looking askew at Big Pharma these days. mark for My Articles similar articles